PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Immunology and Infectious Diseases, Cochin-Hôtel-Dieu Hospital, Assistance Publique -Hôpitaux de Paris (APHP), Hôpitaux Universitaires Paris Centre - Université de Paris.\', \'University of Paris School of Medicine.\', \'Antimicrobial Stewardship Team, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Paris Centre-Site Cochin.\', \'Department of Pneumology, Cochin-Hôtel-Dieu Hospital, Assistance Publique -Hôpitaux de Paris (APHP), Paris.\', \'Clinical Research Unit, Department of Public Health, Henri Mondor Hospital, AP-HP.\', \'University Paris-Est Créteil (UPEC) School of Medicine.\', \'INSERM U955, IMRB- CEpiA team, Henri Mondor Hospital, APHP, Créteil, France.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1097/QAD.0000000000002651
?:doi
?:hasPublicationType
?:journal
  • AIDS (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 32773476
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • HIV infection and COVID-19: risk factors for severe disease.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all